[FLOT becomes standard neoadjuvant chemotherapy for adenocarcinoma of the esophagogastric junction and stomach]

Z Gastroenterol. 2017 Sep;55(9):881-882. doi: 10.1055/s-0043-117060. Epub 2017 Sep 12.

[Article in German]

Authors

Christoph Treese, Hannah Harloff, Severin Daum

PMID: 29186642
DOI: 10.1055/s-0043-117060

No abstract available

Publication types

Comment

MeSH terms

Adenocarcinoma
Antineoplastic Combined Chemotherapy Protocols
Esophageal Neoplasms
Esophagogastric Junction*
Humans
Neoadjuvant Therapy*
Stomach Neoplasms